Angioplasty of Left Main - lAriboisiere Registry (ALMA)

Hopital Lariboisière

Status: Completed

Conditions: Coronary Artery Disease

Study type: Observational

Funder types: Other

Identifiers

NCT01725373

LRB-06-012

Details and patient eligibility

About

In patients with unprotected left main disease (ULMD), angioplasty is emerging as an alternative technique. The investigators aimed to determine the rate of major cardiovascular events in patients treated by angioplasty for ULMD in a "real world" registry.

Full description

Current guidelines recommend coronary artery bypass graft surgery as the "gold standard" treatment in patients with unprotected left main disease. However, patients with ULMD and high surgical risk score or favourable anatomy are still referred for angioplasty. Recently, several studies and registries comparing surgery and percutaneous intervention with drug eluting stents report similar results regarding cardiovascular death and myocardial infarction in patients with multivessel coronary artery disease including unprotected left main disease.

The aim of the study is to evaluate major cardiovascular events in a "real world" registry.

Enrollment: 125 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• stable or unstable angina and/or documented ischemia
• 50% de novo ULMD referred for angioplasty

Exclusion criteria

• acute coronary syndrome with ST elevation,
• cardiogenic shock or out of hospital cardiac arrest

Trial design

125 participants in 1 patient group

Angioplasty of left main

Description:

Patients with: * stable or unstable angina and/or documented ischemia * de novo ≥50% stenosis in the left main stem referred for angioplasty